Vir Biotechnology, Inc. VIR Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating lease liabilities?
- Vir Biotechnology, Inc. (VIR) reported operating lease liabilities of $86.64M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating lease liabilities changed year-over-year?
- Vir Biotechnology, Inc.'s operating lease liabilities decreased by 1.7% year-over-year, from $88.17M to $86.64M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s operating lease liabilities has grown at a 6.0% compound annual growth rate (CAGR), from $66.56M to $89.05M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.